Antibiotics prescription to decrease progression-free survival (PFS) and overall survival (OS) in patients with advanced cancers treated with PD1/PDL1 immune checkpoint inhibitors.
暂无分享,去创建一个
L. Zitvogel | J. Soria | G. Zalcman | F. Goldwasser | B. Escudier | D. Enot | B. Besse | Y. Loriot | B. Routy | L. Mezquita | C. Massard | L. Albiges | S. Brosseau | L. Derosa | M. Fidelle | C. Naltet | A. Goubet